Considerations in the pharmacoeconomics of dry eye
Hirsch, J.D.
Managed Care 12(12 Suppl): 33-38
2003
ISSN/ISBN: 1062-3388 PMID: 14723112 Document Number: 560453
Dry eye disease diminishes the quality of patients' lives and drives utilization of health care resources. Until recently, all treatments for dry eye have been palliative. A new treatment, cyclosporine A ophthalmic emulsion, addresses the disease's underlying causes. It warrants pharmacoeconomic analysis to determine its place in managed care.
Document emailed within 1 workday
Related Documents
Jahnz-Rózyk, K. 2008: Antibiotic pharmacoeconomics Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 25(149): 437-438Whitehouse, P.J. 1997: Pharmacoeconomics of dementia Alzheimer Disease and Associated Disorders 11 Suppl. 5: S22
Beresniak, A.; Bouvenot, G. 2000: Significance of pharmacoeconomics Presse Medicale 29(23): 1299-1301
Pérez, J.H. 2000: Pharmacoeconomics and antimicrobials Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 13(2): 159-160
Douglas, B. 2007: Rational pharmacoeconomics? New Zealand Medical Journal 120(1255): U2569
Czech, M. 2004: Pharmacoeconomics in contemporary medicine Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 16(Suppl 1): 16-19
Hanson, M.A. 1999: Pharmacoeconomics of schizophrenia in the 21st century Journal of Clinical Psychiatry 60(Suppl): 26-27; Discussion 28-30
Incorvaia, C.; Agostinis, F.; Amoroso, S.; Ariano, R.; Barbato, A.; Bassi, M.; Cadario, G.; Campi, P.; Cardinale, F.; Romano, C.; Ciprandi, G.; D'Anneo, R.; Dal Bo, S.; Di Gioacchino, M.; Fiocchi, A.; Galimberti, M.; Galli, E.; Giovannini, M.; La Grutta, S.; Lombardi, C.; Marcucci, F.; Marseglia, G.L.; Mastrandrea, F.; Minelli, M.; Nettis, E.; Novembre, E.; Ortolani, C.; Pajno, G.; Piras, P.P.; Passalacqua, G.; Patriarca, G.; Pucci, S.; Quercia, O.; Romano, A.; Schiavino, D.; Sforza, M.; Tosca, M.A.; Tripodi, S.; Zambito, M.; Puccinelli, P.; Frati, F. 2007: Pharmacoeconomics of subcutaneous allergen immunotherapy European Annals of Allergy and Clinical Immunology 39(Special Issue): 17-20
Stepińska, J.; Niewada, M. 2003: Pharmacoeconomics in clinical practice--infective endocarditis Kardiologia Polska 58(Suppl 2): Ii5-Ii8
Tsai, C.-P. 2010: Pharmacoeconomics of intravenous immunoglobulin in various neurological disorders Acta Neurologica Taiwanica 19(4): 303-308
Zhang, F.; Zhou, C.-F. 2007: Illumination of pharmacoeconomics on Chinese herbal medicine inject Zhongguo Zhong Yao Za Zhi 32(5): 453-456
Díaz de Rojas, F. 1997: Pharmacoeconomics: the basic concepts and their application to digestive medicine Gastroenterologia y Hepatologia 20(2): 68-77
Barry, M.; Heerey, A.; McCulloch, D.; Ryan, M.; Merry, C.; Hughes, C.; Feely, J. 1999: The Irish National Centre of Pharmacoeconomics: its rationale and role Irish Medical Journal 92(4): 337-339
Eisenberg, P.D. 1994: Further profiles of granisetron (Kytril): effect on quality of life and pharmacoeconomics Seminars in Oncology 21(3 Suppl 5: 26-29
Wilson, T.W.; Chockalingam, A.; Quest, D.W. 1996: Pharmacoeconomics of hypertension control: basic principles of economic evaluation Journal of Human Hypertension 10(Suppl 2): S19-S22
Mauro, M.; Russello, M.; Alesina, R.; Sillano, V.; Alessandrini, A.; Dama, A.; Passalacqua, G.; Senna, G. 2006: Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one European Annals of Allergy and Clinical Immunology 38(1): 31-34
Vogel, J.P.; Oxman, A.D.; Glenton, C.; Rosenbaum, S.; Lewin, S.; Gülmezoglu, A.Metin.; Souza, Jão.Paulo. 2013: Policymakers' and other stakeholders' perceptions of key considerations for health system decisions and the presentation of evidence to inform those considerations: an international survey Health Research Policy and Systems 11: 19
Yap, U.J.; Ong, G. 1994: Periodontal considerations in restorative dentistry. 1: Operative considerations Dental Update 21(10): 413-418
Tholen, B. 2009: Privileging the near and dear?: Evaluating special ties considerations in EU migration policy - Privilégier le proche et le chérir. Évaluer les considérations de liens spéciaux dans la politique de migration de l'UE Ethnicities (London) 9(1): 32-52
Jenaro Garrido, J.M. 1986: Obras de fabrica resistentes. Consideraciones generales de calculo - Ouvrages porteurs en maçonnerie. Considérations générales de calcul - Bearing masonry works. General considerations upon calculating method Informes de la Construccion 38(384): 35-50